-+ 0.00%
-+ 0.00%
-+ 0.00%

VERTEX PHARMACEUTICALS: RAISES FY26 COMBINED GAAP AND NON-GAAP R&D, AIPR&D, SG&A EXPENSE GUIDANCE TO REFLECT CRINETICS INTEGRATION

Reuters·11/02/2026 21:05:57

Please log in to view news